SUMMARY Synthesis of prostaglandins (PGE2, PGI2 and PGF2,:) and thromboxane A2 was investigated in short term incubates of duodenal mucosa biopsies. Mucosa close to the ulcer site synthesised significantly less PGF2a (p<0.001) and PGI2 (p<0-002) measured as its stable metabolite 6-oxo-PGF1, than healthy mucosa from non-ulcer patients. In paired biopsies taken from the ulcer site and opposite the ulcer in the same patient PGF20, and PGI2 syntheses were both significantly and similarly depressed when compared with normal mucosa. Synthesis of PGE2 and TxA2 (as its stable metabolite TxB2) was not different in any tissue. There is a defect in the ability of the human duodenal mucosa in duodenal ulcer disease to synthesise PGF20, and PGI2; the defect is not limited to the ulcer site.
Investigations into the pathogenesis of peptic ulceration and intestinal mucosal injury produced by non-steroidal anti-inflammatory drugs and other damaging agents such as alcohol suggest that the prostaglandins maintain mucosal integrity and accelerate ulcer healing. 1-4
The mechanisms underlying these beneficial actions are uncertain but studies (mainly with PGE2) have shown that it can increase mucus5-6 and bicarbonate7 secretion. PGE2 can also inhibit acid secretion, increase gastric mucosal blood flow8 and prevent ion flux and potential difference changes produced by noxious stimuli. '91 Despite this substantial knowledge of the capabilities of PGE2, information of the actual synthesis and content of PGE2 and other cyclooxygenase derived metabolites (eicosanoids) in gastric and duodenal mucosa of ulcer patients is limited. Moreover, there are several discordant results (see Discussion) and it is probable that extrapolation of results from patients with gastric ulcers will not be valid for duodenal ulceration because of the differences in the types and quantities of prostaglandins synthesised along the gastrointestinal tract. In this study we have examined the synthesis of the prostaglandins (PG), PGE2, PGF2<, thromboxane A2 (as its stable metabolite TxB2) in duodenal mucosa.
Methods

DUODENAL MUCOSAL BIOPSIES
Duodenal mucosa was obtained from 32 subjects with active duodenal ulceration and from 27 subjects undergoing upper gastrointestinal endoscopy for abdominal symptoms later ascribed to irritable bowel. In subjects with duodenal ulcers, the biopsies were taken from within 3 mm of the ulcer and in subjects without ulceration, from the duodenal cap. In 19 patients two biopsies were taken: one close to the ulcer site and another from the duodenal cap directly opposite the ulcer. The PG or TxB2 content of 01 and 0-2 ml of unknown samples was measured and results accepted only if they showed concordance with the standards which were always assessed in parallel. Blank values obtained by passing Krebs solution through the entire procedure were included. In 12 experiments the mean blank values for 0-1 ml of the 2 ml reconstituted extracts were (pg±SD) 3 0±2 1 (PGE2), 4 0±2 5 (PGF2J), 3 4±2-9 (6-oxo-PGFI,) and 2 3±2 0 (TxB2). All samples were assayed in duplicate and in four separate samples the PGs and TxB2 were measured in two consecutive assays to assess reproducibility. The results showed good agreement with no significant difference between estimates in the two assays. Because of the small biopsy samples a more extensive evaluation of the reproducibility of the assays was not possible. In studies in this laboratory, however, on PG synthesis by colonic mucosa and using identical methods, the intra-assay coefficient of variation for PGE2 was 9 .5% (n=8) and for PGF2a was 9 09% (n=7). The respective intraassay coefficients of variation were 9*0% (n=7) and 8 3% (n=7 The term synthesis is used in this paper to describe the accumulation of eicosanoids in the incubation medium. 6-oxo-F,1 and TxB2 would not be subject to further metabolic degradation and in the absence of added NAD the metabolism of PGF2, and PGE2 would be minimal.
Results Table 1 shows the eicosanoids synthesised by healthy, non-ulcerated mucosa in a group of 27 patients without duodenal ulceration compared with biopsies taken close to the ulcer site in 32 separate patients with duodenal ulceration. During 60 minutes incubation, synthesis of PGF2, and 6-oxo-PGFI, by ulcer tissue was reduced by 45 4% and 47 6% respectively when compared with that synthesised by control mucosa, whereas PGE2 and TxB2 showed no differences between control and ulcer subjects. 3 showed no reduction in 6-oxo-PGF1,,, accumulation in culture fluid of incubated duodenal mucosa from ulcer patients; however, like this study they showed no diminished PGE2 or TxB2 accumulation. Other investigators also showed no change in PGE2 synthesis in the duodenum from patients with ulcers compared with healthy duodenal mucosa. '4 Evidence for a more general mucosal defect in eicosanoid synthesis has been suggested"1 as seemingly healthy gastric mucosa from patients with duodenal ulceration synthesised less PGE2, 6- 
